StonvexLoading…
StonvexStonvexStonvexCore line items from CTSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $21.11B | $19.74B | $19.35B | $19.43B |
Operating Income | $3.39B | $2.89B | $2.69B | $2.97B |
Net Income | $2.23B | $2.24B | $2.13B | $2.29B |
EPS (Diluted) | $4.56 | $4.51 | $4.21 | $4.41 |
Total Assets | $20.69B | $19.97B | $18.48B | $17.85B |
Total Liabilities | $5.68B | $5.56B | $5.26B | $5.54B |
Cash & Equivalents | $1.90B | $2.23B | $2.62B | $2.19B |
Free Cash Flow OCF − CapEx | $2.60B | $1.83B | $2.01B | $2.24B |
Shares Outstanding | 479.00M | 495.00M | 498.00M | 509.00M |